Nationwide Fund Advisors’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
NIMC
WC
RA
HA
TAM
Nationwide Fund Advisors's LFCR Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Lifecore Biomedical (LFCR) in Q4 2017, closing a stake of 19,025 shares — an estimated $246K sold.
Nationwide Fund Advisors first reported a position in LFCR in Q2 2013 and held it in 18 quarters. The position peaked at $423K in Q4 2014. 91 funds tracked by Wall St. Rank hold LFCR as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Lifecore Biomedical position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 19,025 Lifecore Biomedical shares in Q4 2017, an estimated $246K.
- Nationwide Fund Advisors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's Lifecore Biomedical position peaked at $423K in Q4 2014.
- 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.